Close
Close
Sickle Cell Disease Vepoloxamer (MST-188)
270 views
1.5
1.5 from 2 votes

Vepoloxamer (MST-188) is an investigational drug designed to minimize the deleterious effects of a sickle cell crisis that may bring an epic change to the treatment of sickle cell disease.

Learn more about:

Access Programs

by Scott Harwood
7 views 3 days ago
by Abidemi Uruejoma
8 views 3 days ago
by Scott Harwood
9 views 4 days ago
by Scott Harwood
16 views 1 week ago
by Scott Harwood
11 views 1 week ago
1.5
1.5 from 2 votes
Free Newsletter
Find a Clinical Trial
Related Videos
by Abidemi Uruejoma
759 views
by Abidemi Uruejoma
10,181 views